rs147679793
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_016492.5(RANGRF):c.172G>A(p.Val58Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000837 in 1,613,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V58L) has been classified as Uncertain significance.
Frequency
Consequence
NM_016492.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RANGRF | NM_016492.5 | c.172G>A | p.Val58Ile | missense_variant | Exon 2 of 5 | ENST00000226105.11 | NP_057576.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RANGRF | ENST00000226105.11 | c.172G>A | p.Val58Ile | missense_variant | Exon 2 of 5 | 1 | NM_016492.5 | ENSP00000226105.6 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152242Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000148 AC: 37AN: 249458 AF XY: 0.000126 show subpopulations
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461476Hom.: 0 Cov.: 32 AF XY: 0.0000454 AC XY: 33AN XY: 727060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000427 AC: 65AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74386 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
The c.172G>A (p.V58I) alteration is located in exon 2 (coding exon 2) of the RANGRF gene. This alteration results from a G to A substitution at nucleotide position 172, causing the valine (V) at amino acid position 58 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Benign:1
Cardiac arrhythmia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at